(Total Views: 518)
Posted On: 04/26/2022 10:04:02 PM
Post# of 148908
I was just reading about Remdesivir, it having been the therapeutic in 800,000 deaths here and it turns out Gilead was allowed to change the end points of the Remdesivir trial mid stream! Imagine if we had been allowed to make the CD12 end point 14 days, hello! I think there was a lot of crap going on with our Gilead laden DSMC and with Amarex.
In an interview, H. Clifford Lane, the clinical director at the NIAID, reiterated that the researchers made the change before any data were revealed to them. The decision to make the change, he said in a follow-up email, had been made during a call on March 22. The change had to be approved by the researchers, Gilead, and the Food and Drug Administration; this was done by April 2, Lane said.
In an interview, H. Clifford Lane, the clinical director at the NIAID, reiterated that the researchers made the change before any data were revealed to them. The decision to make the change, he said in a follow-up email, had been made during a call on March 22. The change had to be approved by the researchers, Gilead, and the Food and Drug Administration; this was done by April 2, Lane said.
(4)
(0)Scroll down for more posts ▼
